Markets:

Overview

News

Currencies

International

Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

8.700 +0.280 (+3.33%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

65 66 Next >

Resilient Stocks Look To Break Free As Nasdaq, S&P 500 Futures Climb: Brace For More Volatility, Sideways Movement Near Term, Says Analyst ↗

March 01, 2023

Stocks could attempt to return to their winning ways on Wednesday following the lackluster performance in the previous session. Mixed earnings news flow could, however, act as a dampener. Cues From...

Via Benzinga

Novavax, AMC Entertainment And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

March 01, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Tesla, Apple, AMC, Novavax, Rivian: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

February 28, 2023

Via Benzinga

Novavax Stock Down On Concern Over Whether The Company Can Continue ↗

February 28, 2023

Novavax warns that it may not be able to continue as a company.

Via Talk Markets

Here's The Good News For Novavax Ahead Of Its Fourth-Quarter Report ↗

February 28, 2023

Novavax is expected to report strong sales growth. But 2023 guidance will be key.

Via Investor's Business Daily

Earnings Preview: Novavax ↗

February 27, 2023

Via Benzinga

Why Novavax Stock Wilted on Wednesday ↗

February 22, 2023

It doesn't seem like investors are looking forward to the company's fourth-quarter and full-year 2022 earnings release.

Via The Motley Fool

Rivian's Slamming on the Brakes, but This Vaccine Stock Is Falling Harder ↗

February 28, 2023

A couple of high-profile companies posted big declines in after-hours trading on Tuesday.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 28, 2023

Via Benzinga

After-Hours Alert: Why Novavax Stock Is Plunging ↗

February 28, 2023

Novavax Inc (NASDAQ: NVAX) shares are tanking in Tuesday's after-hours session after the company reported weak fourth-quarter re

Via Benzinga

2 Stocks to Sell or Remove From Your Watchlist in 2023 ↗

February 28, 2023

Both stocks soared during the coronavirus vaccine race, but their time has passed.

Via The Motley Fool

Coronavirus Vaccine Market To Surpass $95 Billion By 2028

February 28, 2023

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NASDAQ:NVAX),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

Via FinancialNewsMedia

More Likely to 5x First: Novavax vs. Ocugen ↗

February 16, 2023

They skyrocketed before. It could happen again.

Via The Motley Fool

Nasdaq, S&P 500 Futures Flatline Ahead Of Housing, Consumer Data: Analyst Pins Hopes On Dollar, Fed Rates To Keep Flickering Rally Hopes Alive ↗

February 28, 2023

Trading in the U.S. index futures suggests stocks may start Tuesday’s session slightly higher, although the mood could be cautious ahead of some key economic data on the housing market, business...

Via Benzinga

Earnings Scheduled For February 28, 2023 ↗

February 28, 2023

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.

Via Benzinga

3 Supercharged Growth Stocks Down 89% to 97% That Billionaires Can't Stop Buying ↗

February 23, 2023

Beaten-down growth stocks were popular buys during the fourth quarter for some of the brightest billionaire money managers.

Via The Motley Fool

2 Beaten-Down Stocks That Might Be too Cheap to Ignore ↗

February 22, 2023

There is an argument for hitting the buy button, but it's important to consider the potential risks too.

Via The Motley Fool

Harmony Biosciences, The No. 3 Biotech, Just Topped Forecasts; But Concerns Persist ↗

February 21, 2023

The company offered neither financial guidance nor plans for a new CEO.

Via Investor's Business Daily

Is This the Telltale Sign to Sell Novavax Stock? ↗

February 14, 2023

You won't find Novavax's latest bad news trumpeted in a press release.

Via The Motley Fool

Why Is Monday.com (MNDY) Stock Up 11% Today? ↗

February 13, 2023

Monday.com (MNDY) stock is on the rise Monday after announcing a partnership with Appfire to expand its app marketplace.

Via InvestorPlace

NVAX Stock Alert: Novavax Will Provide 1.5 Million More Covid-19 Vaccine Doses to U.S. ↗

February 13, 2023

Novavax (NVAX) stock is on the move Monday after extending its Covid-19 vaccine supply agreement with the U.S. government.

Via InvestorPlace

These Cheap Growth Stocks Could Supercharge Your Portfolio ↗

February 12, 2023

All of these players are cheap today considering their growth potential.

Via The Motley Fool

Is Novavax Stock a Buy With the New Normal for COVID? ↗

February 10, 2023

The landscape has shifted dramatically in the COVID-19 vaccine market.

Via The Motley Fool

Better Buy: Novavax or BioNTech Stock? ↗

February 04, 2023

The two companies, known for their vaccines, could see their businesses benefit from a yearly COVID-19 shot.

Via The Motley Fool

MarketBeat Week in Review – 1/30 - 2/3

February 04, 2023

The markets are trending lower to end the week. It’s hard to figure out the markets after the blockbuster job report, but the MarketBeat team gave it a shot

Via MarketBeat

3 Sorry Pharma Stocks to Sell in February Before It’s Too Late ↗

February 01, 2023

These are the pharma stocks to sell, as they represent companies with weak fundamentals and sustained cash burn visibility.

Via InvestorPlace

Novavax Shares Jumped in January While Others Slipped

February 01, 2023

Updated FDA Covid vaccine policy could've boosted NVAX shares at the end of January, when other pharma stocks slipped, but it may not affect the bottom line.

Via MarketBeat

1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell ↗

February 01, 2023

Novavax shares sank 93% last year.

Via The Motley Fool

$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns ↗

January 30, 2023

The COVID-19 pandemic emerged in 2019 in China and spread to the rest of the globe in early 2020. Since then, the virus has caused more than 6.8 million deaths.

Via Benzinga

Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip ↗

January 27, 2023

The FDA's experts voted in favor of annual boosters on Thursday.

Via Investor's Business Daily

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

65 66 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Novavax, Inc. - Common Stock (NQ:NVAX)

All News about Novavax, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today